SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950115-99-001352
Filing Date
1999-10-29
Accepted
1999-10-29 00:00:00
Documents
2
Period of Report
1998-10-31

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT 10-Q/A 44409
2 FDS EX-27 2235
  Complete submission text file 0000950115-99-001352.txt   48163
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-25169 | Film No.: 99737763
SIC: 2834 Pharmaceutical Preparations